Lifastuzumab (Anti-SLC34A2)

Lifastuzumab (Anti-SLC34A2) is a monoclonal antibody targeting SLC34A2 (sodium phosphate 2 transporter(NaPi2b)). It has anticancer activity and can be used in research of ovarian cancer (OC).
Supplier Selleck Chemicals
Product # A3163
Sku # A3163-1mg
Pricing 1mg, $370.00
Feedback